Imaging Technology

JULY 28, 2023

POSLUMA is widely available through 36 radiopharmacies in the national network of Blue Earth Diagnostics’ commercial U.S. The addition of POSLUMA to the highly respected NCCN Guidelines is a major milestone for Blue Earth Diagnostics,” said David E. Chief Medical Officer of Blue Earth Diagnostics. Teoh, MBBS, MRCP, FRCR, D.Phil.,

Diagnostic 98

Diagnostic Clinic Radiopharmaceuticals Radiation 98

Imaging Technology

MAY 30, 2023

milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. It is the first and only FDA-approved, PSMA-targeted imaging agent developed with proprietary radiohybrid (rh) technology.

Diagnostic 97

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging 97

AuntMinnie

MARCH 15, 2024

A 2018 study from the U.S. The promise of precision Radiation therapy has already proven to play a pivotal role in the treatment of prostate cancer, offering a targeted and effective approach to eliminating cancerous cells. Americans today can expect to live long lives.

Radiopharmaceuticals 105

Radiopharmaceuticals Radiation Disease Diagnostic Imaging 105

AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

The British Institute of Radiology

SEPTEMBER 11, 2023

I graduated with my radiography degree in 2018 and since then I’ve worked in a wide variety of departments, from plain film to nuclear medicine. Prior to my current position, I’ve spent time as a Radiation Protection Supervisor, and well as a trainer for graduate and post graduate radiographers.

Radiography 52

Radiography Radiograph Radiographer Radiographer 52

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

OCTOBER 5, 2023

We are pleased to present these results from the LIGHTHOUSE study to the radiation oncology community at ASTRO,” said David E. Chief Executive Officer of Blue Earth Diagnostics. The findings were discussed in a poster Q&A session at the 2023 ASTRO Annual Meeting on October 3, 2023 ,“ Diagnostic Performance of 18 F-rhPSMA-7.3

Diagnose 52

Diagnose Diagnostic Disease Radiation 52